a new foundation for yourdoc doc … plc pembrolizumab merck & co pen-221 ... doc xls htm ppt...

4
Unknown ute lle a, Irvine Graz Phase I NCT02035657 Immune Design NCT02831179 National Cancer Institute NCT03212404 Checkpoint Therapeutics NCT02890368 Trillium NCT03000257 AbbVie NCT03071757 AbbVie NCT03107663 ImaginAb NCT00655655 National Cancer Institute NCT00346385 ImmunoGen NCT01155258 Pfizer NCT01204476 National Cancer Institute NCT01652547 Novartis NCT00002947 National Cancer Institute Phase I/II NCT03167164 NantWorks NCT03241173 Incyte Corporation NCT02488759 BMS NCT02514824 Millennium NCT02584829 Fred Hutchinson Cancer Research C NCT02643303 MedImmune NCT02936323 Tarveda NCT03126110 Incyte Corporation NCT01758458 Fred Hutchinson Cancer Research C DOC HTM XLS PPT A new foundation for your competitive intelligence, regulatory strategy, and clinical trial design. BizInt Solutions, Inc. | www.bizint.com bizdash.bizint.com

Upload: hahuong

Post on 15-May-2018

217 views

Category:

Documents


1 download

TRANSCRIPT

Clinical, Phase Unknown

NCT03089658Merck KGaA/Pfizer

NCT02471352National Cancer Institute

NCT03210935University Hospital, Lille

NCT00540566University of California, Irvine

NCT00765193Medical University of Graz

NCT01526486Emory University

Phase I

NCT02035657Immune Design

NCT02831179National Cancer Institute

NCT03212404Checkpoint Therapeutics

NCT02890368Trillium

NCT03000257AbbVie

NCT03071757AbbVie

NCT03107663ImaginAb

NCT00655655National Cancer Institute

NCT00346385ImmunoGen

NCT01155258Pfizer

NCT01204476National Cancer Institute

NCT01652547Novartis

NCT00002947National Cancer Institute

Phase I/II

NCT03167164NantWorks

NCT03241173Incyte Corporation

NCT02488759BMS

NCT02514824Millennium

NCT02584829Fred Hutchinson Cancer Research Center

NCT02643303MedImmune

NCT02936323Tarveda

NCT03126110Incyte Corporation

NCT01758458Fred Hutchinson Cancer Research Center

Phase II

NCT02054884Philogen

NCT02978625National Cancer Institute

2011-003226-27GSK

2014-004735-39Novartis

2016-000461-23BMS

NCT02155647Merck KGaA

NCT02196961BMS

NCT02351128University Hospital, Grenoble

NCT02465957NantWorks

NCT02819843Amgen

NCT03071406BMS

NCT01013779Trans-Tasman Radiation Oncology Group (TROG)

NCT02036476Exelixis

NCT02267603National Cancer Institute

NCT00003549National Cancer Institute

NCT00004922National Cancer Institute

NCT00068783National Cancer Institute

NCT00079131National Cancer Institute

NCT00869050Columbia University

NCT01440816OncoSec Medical Incorporated

NCT00003514Burzynski Research Institute

NCT01913691National Cancer Institute

Phase III

2010-023827-34POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Phase IV

2005-000402-32Genetronics Biomedical Corporation

NCT01794793Novartis

Overall Status

Unknown status

Available

Planned

Ongoing

Open, Recruiting

Active, Not Recruiting

Completed

Terminated

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

A new foundation for your competitive intelligence, regulatory strategy,

and clinical trial design.

GET STARTED!

BizInt Solutions, Inc. | www.bizint.com

The starting point for your BizDash project is to request a quote for your project. We’ll do a quick query on your indication or area of interest and get back to you with a quote.

Visit bizdash.bizint.com and request a no-obligation quote.

bizdash.bizint.com

If you subscribe to drug pipeline databases such as Citeline Pharmaprojects or Cortellis from Clarivate Analytics, we can augment your Dashboards with tabular reports and visualizations based on your pipeline search results.

The value-added information and indexing found in drug pipeline databases facilitates answering questions such as:

• Who are the key competitors for our compound?

• What types of drugs (i.e. biologics, small molecules, etc.) are being investigated for our indication?

• What is the route of administration (ROA) breakdown for key competitor drugs?

Gain additional insights from pipeline data

bizdash.bizint.com

© 2017 BizInt Solutions, Inc | www.bizint.com 1

Biological Testing

Merkel cell carcinoma therapies Vironika

Preclinical

CK-301 TG Therapeutics

ETBX-051 NantWorks

ETBX-061 NantWorks

ipilimumab Bristol-Myers Squibb Co

LTvax APCure

Merkel cell polyomavirus inhibitors Vironika

Phase I

BGB-A317 Celgene

ID-G100 Immune Design

pasireotide Novartis

SIRPa-Fc Trillium Therapeutics

utomilumab Pfizer

Phase II

ALT 803 Altor BioScience Corporation

cabozantinib S-malate Exelixis

CST-101 NantWorks

F16-IL2 Philogen

MCPyV vaccine Fred Hutchinson Cancer Research Center

nivolumab Ono Pharmaceutical Co Ltd

pazopanib GlaxoSmithKline plc

pembrolizumab Merck & Co

PEN-221 Tarveda Therapeutics

sapanisertib Intellikine

talimogene laherparepvec BioVex Inc

tavokinogene telsaplasmid OncoSec Medical

Launched

avelumab Merck KGaA

Discontinued

lorvotuzumab mertansine ImmunoGen

No Development Reported

ATN-161 Attenuon

tivantinib ArQule

Type of molecule

Antibody

Biological, other

Cell & gene therapy

Protein & peptide

Small molecule therapeutic

Vaccine

Merkel cell carcinoma (MCC) pipeline: Phase for MCC and type of molecule

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Solutions, Inc.600 First Avenue Seattle, WA 981041.714.289.1000

www.bizint.com

BizInt tools turn data into intelligence as a foundation for strategic decisions.

The BizInt Smart Charts product family is used by pharmaceutical, biotech, chemical and device/diagnostics companies worldwide to support product lifecycle planning and portfolio management.

© 2017 BizInt Solutions, Inc. 09/2017

TIER 2All Tier 1 Items + PowerPoint Deck of Visualizations

and additional items

Support your analysisFor over 20 years, BizInt Smart Charts tools have

been used by analysts in top pharmaceutical

and biotech companies to create reports and

visualizations to support their decision-making.

Don’t have the time to learn and use

the BizInt Smart Charts tools yourself?

BizInt will search the trial registry databases

and use our tools to build BizInt Smart Strategy

Dashboards (BizDash) for you, helping you answer

questions like —

• Where are trials ongoing for our indication?

• When are trials in each phase scheduled

to complete?

• What primary endpoints are being used in

competitor trials

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

Dashboard includes a BizInt Smart Charts tabular report integrating search results from clinical trial registries.

• Search NIH Clinical Trials.gov, EU Clinical Trials (EudraCT) and WHO ICTRP.

• Trials matched across databases and summarized in one row using BizInt tools.

• Create summary columns (such as a summary of trial enrollment by country.)

• Clean-up trial phases, company names and other key fields using BizInt tools.

• Deliver in formats shown below.

PRICING

Pricing starts at $1500 and is based on your search topic.

BizDash Tier 1 includes use of BizInt Smart Charts for Clinical Trials for 3 months.

FILE FORMATS

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

Tier 1 Features and Deliverables

Dashboard includes PowerPoint slides and interactive browser visualizations, based on the Tier 1 Table.

• Use BizInt tools and Excel to create a portfolio of visualizations developed for trial analysis.

• Additional data clean-up and filtering using BizInt tools.

• Some visualizations provide links to trial records on registries.

• Visualizations provided in formats that can be used with your portal, reports, and presentations.

PRICING

Pricing starts at $3500 and includes all Tier 1 deliverables.

BizDash Tier 1 and Tier 2 include one round of feedback and revisions.

FILE FORMATS

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

Tier 2 Features and Deliverables

Clinical, Phase Unknown

NCT03089658 Merck KGaA/Pfizer

NCT02471352National Cancer Institute

NCT03210935University Hospital, Lille

NCT00540566University of California, Irvine

NCT00765193Medical University of Graz

NCT01526486Emory University

Phase I

NCT02035657Immune Design

NCT02831179National Cancer Institute

NCT03212404Checkpoint Therapeutics

NCT02890368Trillium

NCT03000257AbbVie

NCT03071757AbbVie

NCT03107663ImaginAb

NCT00655655National Cancer Institute

NCT00346385ImmunoGen

NCT01155258Pfizer

NCT01204476National Cancer Institute

NCT01652547Novartis

NCT00002947National Cancer Institute

Phase I/II

NCT03167164NantWorks

NCT03241173Incyte Corporation

NCT02488759BMS

NCT02514824Millennium

NCT02584829Fred Hutchinson Cancer Research Center

NCT02643303MedImmune

NCT02936323Tarveda

NCT03126110Incyte Corporation

NCT01758458Fred Hutchinson Cancer Research Center

Phase II

NCT02054884Philogen

NCT02978625National Cancer Institute

2011-003226-27GSK

2014-004735-39Novartis

2016-000461-23BMS

NCT02155647Merck KGaA

NCT02196961BMS

NCT02351128University Hospital, Grenoble

NCT02465957NantWorks

NCT02819843Amgen

NCT03071406BMS

NCT01013779Trans-Tasman Radiation Oncology Group (TROG)

NCT02036476Exelixis

NCT02267603National Cancer Institute

NCT00003549National Cancer Institute

NCT00004922National Cancer Institute

NCT00068783National Cancer Institute

NCT00079131National Cancer Institute

NCT00869050Columbia University

NCT01440816OncoSec Medical Incorporated

NCT00003514Burzynski Research Institute

NCT01913691National Cancer Institute

Phase III

2010-023827-34POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Phase IV

2005-000402-32Genetronics Biomedical Corporation

NCT01794793Novartis

Overall Status

Unknown status

Available

Planned

Ongoing

Open, Recruiting

Active, Not Recruiting

Completed

Terminated

Merkel cell carcinoma trials by status – all trials

Background: Data from ClinicalTrials.gov and the EU Clinical Trials Registry was integrated in BizInt Smart Charts, cleaned up and visualized with VP-SCE. Values shown are those reported by the databases.

TIER 1BizInt Smart Charts Table and File Exports

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Solutions, Inc. | 1.714.289.1000 | www.bizint.com

dashboard [noun]

a visual display of the most important

information needed to achieve one or

more objectives.

bizdash.bizint.com

TIER 2All Tier 1 Items + PowerPoint Deck of Visualizations

and additional items

Support your analysisFor over 20 years, BizInt Smart Charts tools have

been used by analysts in top pharmaceutical

and biotech companies to create reports and

visualizations to support their decision-making.

Don’t have the time to learn and use

the BizInt Smart Charts tools yourself?

BizInt will search the trial registry databases

and use our tools to build BizInt Smart Strategy

Dashboards (BizDash) for you, helping you answer

questions like —

• Where are trials ongoing for our indication?

• When are trials in each phase scheduled

to complete?

• What primary endpoints are being used in

competitor trials

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

Dashboard includes a BizInt Smart Charts tabular report integrating search results from clinical trial registries.

• Search NIH Clinical Trials.gov, EU Clinical Trials (EudraCT) and WHO ICTRP.

• Trials matched across databases and summarized in one row using BizInt tools.

• Create summary columns (such as a summary of trial enrollment by country.)

• Clean-up trial phases, company names and other key fields using BizInt tools.

• Deliver in formats shown below.

PRICING

Pricing starts at $1500 and is based on your search topic.

BizDash Tier 1 includes use of BizInt Smart Charts for Clinical Trials for 3 months.

FILE FORMATS

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

Tier 1 Features and Deliverables

Dashboard includes PowerPoint slides and interactive browser visualizations, based on the Tier 1 Table.

• Use BizInt tools and Excel to create a portfolio of visualizations developed for trial analysis.

• Additional data clean-up and filtering using BizInt tools.

• Some visualizations provide links to trial records on registries.

• Visualizations provided in formats that can be used with your portal, reports, and presentations.

PRICING

Pricing starts at $3500 and includes all Tier 1 deliverables.

BizDash Tier 1 and Tier 2 include one round of feedback and revisions.

FILE FORMATS

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

Tier 2 Features and Deliverables

Clinical, Phase Unknown

NCT03089658 Merck KGaA/Pfizer

NCT02471352National Cancer Institute

NCT03210935University Hospital, Lille

NCT00540566University of California, Irvine

NCT00765193Medical University of Graz

NCT01526486Emory University

Phase I

NCT02035657Immune Design

NCT02831179National Cancer Institute

NCT03212404Checkpoint Therapeutics

NCT02890368Trillium

NCT03000257AbbVie

NCT03071757AbbVie

NCT03107663ImaginAb

NCT00655655National Cancer Institute

NCT00346385ImmunoGen

NCT01155258Pfizer

NCT01204476National Cancer Institute

NCT01652547Novartis

NCT00002947National Cancer Institute

Phase I/II

NCT03167164NantWorks

NCT03241173Incyte Corporation

NCT02488759BMS

NCT02514824Millennium

NCT02584829Fred Hutchinson Cancer Research Center

NCT02643303MedImmune

NCT02936323Tarveda

NCT03126110Incyte Corporation

NCT01758458Fred Hutchinson Cancer Research Center

Phase II

NCT02054884Philogen

NCT02978625National Cancer Institute

2011-003226-27GSK

2014-004735-39Novartis

2016-000461-23BMS

NCT02155647Merck KGaA

NCT02196961BMS

NCT02351128University Hospital, Grenoble

NCT02465957NantWorks

NCT02819843Amgen

NCT03071406BMS

NCT01013779Trans-Tasman Radiation Oncology Group (TROG)

NCT02036476Exelixis

NCT02267603National Cancer Institute

NCT00003549National Cancer Institute

NCT00004922National Cancer Institute

NCT00068783National Cancer Institute

NCT00079131National Cancer Institute

NCT00869050Columbia University

NCT01440816OncoSec Medical Incorporated

NCT00003514Burzynski Research Institute

NCT01913691National Cancer Institute

Phase III

2010-023827-34POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Phase IV

2005-000402-32Genetronics Biomedical Corporation

NCT01794793Novartis

Overall Status

Unknown status

Available

Planned

Ongoing

Open, Recruiting

Active, Not Recruiting

Completed

Terminated

Merkel cell carcinoma trials by status – all trials

Background: Data from ClinicalTrials.gov and the EU Clinical Trials Registry was integrated in BizInt Smart Charts, cleaned up and visualized with VP-SCE. Values shown are those reported by the databases.

TIER 1BizInt Smart Charts Table and File Exports

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Solutions, Inc. | 1.714.289.1000 | www.bizint.com

dashboard [noun]

a visual display of the most important

information needed to achieve one or

more objectives.

bizdash.bizint.com

Clinical, Phase Unknown

NCT03089658Merck KGaA/Pfizer

NCT02471352National Cancer Institute

NCT03210935University Hospital, Lille

NCT00540566University of California, Irvine

NCT00765193Medical University of Graz

NCT01526486Emory University

Phase I

NCT02035657Immune Design

NCT02831179National Cancer Institute

NCT03212404Checkpoint Therapeutics

NCT02890368Trillium

NCT03000257AbbVie

NCT03071757AbbVie

NCT03107663ImaginAb

NCT00655655National Cancer Institute

NCT00346385ImmunoGen

NCT01155258Pfizer

NCT01204476National Cancer Institute

NCT01652547Novartis

NCT00002947National Cancer Institute

Phase I/II

NCT03167164NantWorks

NCT03241173Incyte Corporation

NCT02488759BMS

NCT02514824Millennium

NCT02584829Fred Hutchinson Cancer Research Center

NCT02643303MedImmune

NCT02936323Tarveda

NCT03126110Incyte Corporation

NCT01758458Fred Hutchinson Cancer Research Center

Phase II

NCT02054884Philogen

NCT02978625National Cancer Institute

2011-003226-27GSK

2014-004735-39Novartis

2016-000461-23BMS

NCT02155647Merck KGaA

NCT02196961BMS

NCT02351128University Hospital, Grenoble

NCT02465957NantWorks

NCT02819843Amgen

NCT03071406BMS

NCT01013779Trans-Tasman Radiation Oncology Group (TROG)

NCT02036476Exelixis

NCT02267603National Cancer Institute

NCT00003549National Cancer Institute

NCT00004922National Cancer Institute

NCT00068783National Cancer Institute

NCT00079131National Cancer Institute

NCT00869050Columbia University

NCT01440816OncoSec Medical Incorporated

NCT00003514Burzynski Research Institute

NCT01913691National Cancer Institute

Phase III

2010-023827-34POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Phase IV

2005-000402-32Genetronics Biomedical Corporation

NCT01794793Novartis

Overall Status

Unknown status

Available

Planned

Ongoing

Open, Recruiting

Active, Not Recruiting

Completed

Terminated

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

A new foundation for your competitive intelligence, regulatory strategy,

and clinical trial design.

GET STARTED!

BizInt Solutions, Inc. | www.bizint.com

The starting point for your BizDash project is to request a quote for your project. We’ll do a quick query on your indication or area of interest and get back to you with a quote.

Visit bizdash.bizint.com and request a no-obligation quote.

bizdash.bizint.com

If you subscribe to drug pipeline databases such as Citeline Pharmaprojects or Cortellis from Clarivate Analytics, we can augment your Dashboards with tabular reports and visualizations based on your pipeline search results.

The value-added information and indexing found in drug pipeline databases facilitates answering questions such as:

• Who are the key competitors for our compound?

• What types of drugs (i.e. biologics, small molecules, etc.) are being investigated for our indication?

• What is the route of administration (ROA) breakdown for key competitor drugs?

Gain additional insights from pipeline data

bizdash.bizint.com

© 2017 BizInt Solutions, Inc | www.bizint.com 1

Biological Testing

Merkel cell carcinoma therapies Vironika

Preclinical

CK-301 TG Therapeutics

ETBX-051 NantWorks

ETBX-061 NantWorks

ipilimumab Bristol-Myers Squibb Co

LTvax APCure

Merkel cell polyomavirus inhibitors Vironika

Phase I

BGB-A317 Celgene

ID-G100 Immune Design

pasireotide Novartis

SIRPa-Fc Trillium Therapeutics

utomilumab Pfizer

Phase II

ALT 803 Altor BioScience Corporation

cabozantinib S-malate Exelixis

CST-101 NantWorks

F16-IL2 Philogen

MCPyV vaccine Fred Hutchinson Cancer Research Center

nivolumab Ono Pharmaceutical Co Ltd

pazopanib GlaxoSmithKline plc

pembrolizumab Merck & Co

PEN-221 Tarveda Therapeutics

sapanisertib Intellikine

talimogene laherparepvec BioVex Inc

tavokinogene telsaplasmid OncoSec Medical

Launched

avelumab Merck KGaA

Discontinued

lorvotuzumab mertansine ImmunoGen

No Development Reported

ATN-161 Attenuon

tivantinib ArQule

Type of molecule

Antibody

Biological, other

Cell & gene therapy

Protein & peptide

Small molecule therapeutic

Vaccine

Merkel cell carcinoma (MCC) pipeline: Phase for MCC and type of molecule

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Smart Charts (.chc, .chrr)

MS Word(.doc)

DOC

MS Excel(.xls)

XLS

MS PowerPoint(.ppt)

PPT

HTML (.htm)

HTM

DOC XLS PPTHTM

BizInt Solutions, Inc.600 First Avenue Seattle, WA 981041.714.289.1000

www.bizint.com

BizInt tools turn data into intelligence as a foundation for strategic decisions.

The BizInt Smart Charts product family is used by pharmaceutical, biotech, chemical and device/diagnostics companies worldwide to support product lifecycle planning and portfolio management.

© 2017 BizInt Solutions, Inc. 09/2017